[Therapy of uremic osteopathy. II. Effect of 5,6-trans-25-hydroxycholecalciferol in terminal kidney insufficiency].
D000328:Adult; D002118:Calcium / Q000097:blood / Q000378:metabolism; D002127:Calcium Isotopes; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006801:Humans; D006887:Hydroxycholecalciferols / Q000008:administration & dosage / Q000627:therapeutic use*; D007275:Injections, Intravenous; D007408:Intestinal Absorption; D007676:Kidney Failure, Chronic / Q000150:complications; D008134:Long-Term Care; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D014511:Uremia / Q000188:drug therapy*
D002127:Calcium Isotopes; D006887:Hydroxycholecalciferols; D002118:Calcium
Die Behandlung der urämischen Osteopathie. II. Die Wirkung von 5,6-trans-25-Hydroxycholecalciferol bei terminaler Niereninsuffizienz.